- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01163968
Maximizing Outcomes Needed After Percutaneous Coronary Intervention (PCI) Using Weight Management (MOMENTUM) (MOMENTUM)
September 27, 2023 updated by: University of Nebraska
The purpose of this study is to examine the use of a home-based program to improve weight reduction after percutaneous coronary intervention (PCI) (either a cardiac stent or angioplasty procedure).
Study Overview
Detailed Description
Obesity is an independent risk factor for coronary disease and is prevalent among patients who undergo percutaneous coronary intervention (PCI).
The significance of cardiac disease is often underestimated by patients who undergo PCI, and therefore they are more reticent in modifying their cardiac risk factors such as obesity following PCI.
This issue is particularly problematic for rural populations, given that weight reduction specific programs are often not available in rural communities.
The overall goal of this pilot study is to evaluate a 12 week cognitive behavioral intervention for weight reduction of overweight or obese PCI patients who participate in a rural cardiac rehabilitation (CR) program.
The Maximizing Outcomes Needed After Percutaneous Coronary Intervention (PCI) Using Weight Management (MOMENTUM) intervention is comprised of 6 modules, totaling 52 daily sessions promoting weight reduction, and 4 coaching sessions over the duration of the 12 week MOMENTUM intervention.
The MOMENTUM intervention will be delivered using telehealth methods (Viterion telehealth device will be used to deliver the module content and the telephone to deliver the coaching sessions).
The intervention was purposively designed to overcome access barriers by using delivery modes accessible to patients in rural settings, in their home and at times convenient to their schedule.
A randomized, 2-group, repeated measures experimental design will be used.
Subjects who have had a PCI, are overweight or obese and enroll in a rural cardiac rehabilitation program will be randomized to either the MOMENTUM group (n=25) and or control group (usual care)(n=25).
The primary aim of the study is to compare the differences between the groups on weight reduction (primary outcome), diet behavior and physical activity (secondary outcomes) over time (baseline, 16 weeks, 6 and 9 months after PCI).
The second aim of the study is to to evaluate the feasibility of implementing the MOMENTUM intervention for a larger randomized controlled trial.
The innovation in this pilot study is the use of technology to deliver a comprehensive cognitive-behavioral weight reduction program to those cardiac patients in rural communities who otherwise might not have access to specific weight reduction programs to improve their cardiac risk profile after an acute cardiac event, such as a PCI.
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nebraska
-
Lincoln, Nebraska, United States, 68506
- BryanLGH Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
The sample for the proposed study will be 50 overweight or obese adults who have had a PCI who meet the following criteria:
- planning to participate in cardiac rehabilitation at rural study sites in Saline and Seward counties of Nebraska
- enrolled within 5 days of PCI procedure
- oriented to person, place, and time
- not visually impaired and able to hear
- have telephone service
- cardiologist's approval to participate in this study.
Exclusion Criteria:
- Mental status impairment as determined by a score of > 8 on the Short-Portable Mental Status Questionnaire (SPMSQ)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Weight reduction program
MOMENTUM intervention
|
The Maximizing Outcomes Needed After Percutaneous Coronary Intervention (PCI) Using Weight Management (MOMENTUM) intervention is comprised of 6 modules, totaling 52 daily sessions promoting weight reduction, and 4 coaching sessions over the duration of the 12 week MOMENTUM intervention.
The MOMENTUM intervention will be delivered using telehealth methods (Viterion telehealth device will be used to deliver the module content and coaching sessions).
The intervention was purposively designed to overcome access barriers by using delivery modes accessible to patients in rural settings, in their home and at times convenient to their schedule.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight reduction
Time Frame: 16 weeks after PCI
|
Body Weight
|
16 weeks after PCI
|
|
Weight reduction
Time Frame: 6 months after PCI
|
Body Weight
|
6 months after PCI
|
|
Weight reduction
Time Frame: 9 months after PCI
|
Body Weight
|
9 months after PCI
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diet behavior
Time Frame: 16 weeks after PCI
|
Heart Healthy Eating Self-Efficacy Scale
|
16 weeks after PCI
|
|
Physical Activity behavior
Time Frame: 16 weeks after PCI
|
Actigraph: mean levels of moderate activity
|
16 weeks after PCI
|
|
Abdominal fat content percent (%) change
Time Frame: 16 weeks after PCI
|
Waist Circumference
|
16 weeks after PCI
|
|
Diet behavior
Time Frame: 6 months after PCI
|
Heart Healthy Eating Self-Efficacy Scale
|
6 months after PCI
|
|
Diet behavior
Time Frame: 9 months after PCI
|
Heart Healthy Eating Self-Efficacy Scale
|
9 months after PCI
|
|
Physical Activity behavior
Time Frame: 6 months after PCI
|
Actigraph: mean levels of moderate activity
|
6 months after PCI
|
|
Physical Activity behavior
Time Frame: 9 months after PCI
|
Actigraph: mean levels of moderate activity
|
9 months after PCI
|
|
Abdominal fat content percent (%) change
Time Frame: 6 months after PCI
|
Waist Circumference
|
6 months after PCI
|
|
Abdominal fat content percent (%) change
Time Frame: 9 months after PCI
|
Waist circumference
|
9 months after PCI
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Susan A Barnason, PhD, University of Nebraska
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2010
Primary Completion (Actual)
March 4, 2013
Study Completion (Actual)
March 4, 2013
Study Registration Dates
First Submitted
July 6, 2010
First Submitted That Met QC Criteria
July 15, 2010
First Posted (Estimated)
July 16, 2010
Study Record Updates
Last Update Posted (Actual)
September 29, 2023
Last Update Submitted That Met QC Criteria
September 27, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 0177-09-FB
- 1P20NR011404-01 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on MOMENTUM
-
Children's Hospital Los AngelesMomentum Health Inc.Not yet recruiting
-
Mental Health Services in the Capital Region, DenmarkTrygFonden, Denmark; Odense Patient Data Explorative NetworkCompletedSchizophrenia, Schizotypal and Delusional DisordersDenmark
-
Medical University of ViennaUnknownPustular Palmoplantar PsoriasisAustria